Mauro E - Search Results

1

Risk of Treatment Failure and Death after Ablation in Hepatocellular Carcinoma Patients-A Multiparametric Prediction.

Muñoz-Martínez S, Sapena V, García-Criado Á, Darnell A, Forner A, Belmonte E, Sanduzzi-Zamparelli M, Rimola J, Soler A, Llarch N, Iserte G, Mauro E, Ayuso C, Rios J, Bruix J, Vilana R, Reig M. Muñoz-Martínez S, et al. Among authors: mauro e. Cancers (Basel). 2023 Jun 21;15(13):3269. doi: 10.3390/cancers15133269. Cancers (Basel). 2023. PMID: 37444380 Free PMC article.

2

[Massive pleural effusion in liver cirrhosis without ascites].

Miguel CM, Catuogno P, Tiberio D, Mallea Gil MS, Mauro EL, López Gastón A. Miguel CM, et al. Among authors: mauro el. Acta Gastroenterol Latinoam. 1995;25(5):291-4. Acta Gastroenterol Latinoam. 1995. PMID: 8733255 Spanish.

3

Heterologous adenovirus-vector/messenger RNA regimen is associated with improved severe acute respiratory syndrome coronavirus 2 humoral response in liver transplant recipients.

Mendizabal M, Ducasa N, Benencio P, Anders M, Cairo F, Barbero M, Etcheves P, Alter A, Scarton G, Abraldes JG, Biglione M, Mauro E. Mendizabal M, et al. Among authors: mauro e. Hepatol Commun. 2022 Oct;6(10):2850-2859. doi: 10.1002/hep4.2034. Epub 2022 Jul 28. Hepatol Commun. 2022. PMID: 35903818 Free PMC article.

4

Hepatocellular adenoma in men: Is it time for a precision approach?

Mauro E, Forner A. Mauro E, et al. Liver Int. 2021 Oct;41(10):2246-2248. doi: 10.1111/liv.15050. Liver Int. 2021. PMID: 34547835 No abstract available.

5

Barcelona Clinic Liver Cancer 2022 update: Linking prognosis prediction and evidence-based treatment recommendation with multidisciplinary clinical decision-making.

Mauro E, Forner A. Mauro E, et al. Liver Int. 2022 Mar;42(3):488-491. doi: 10.1111/liv.15180. Liver Int. 2022. PMID: 35194931 No abstract available.

6

Outcome of patients with HCC and liver dysfunction under immunotherapy: a systematic review and meta-analysis.

El Hajra I, Sanduzzi-Zamparelli M, Sapena V, Muñoz-Martínez S, Mauro E, Llarch N, Iserte G, Forner A, Rios J, Bruix J, Reig M. El Hajra I, et al. Among authors: mauro e. Hepatology. 2023 Apr 1;77(4):1139-1149. doi: 10.1097/HEP.0000000000000030. Epub 2023 Jan 13. Hepatology. 2023. PMID: 36632997 Free article.

7

New Challenges in the Management of Cholangiocarcinoma: The Role of Liver Transplantation, Locoregional Therapies, and Systemic Therapy.

Mauro E, Ferrer-Fàbrega J, Sauri T, Soler A, Cobo A, Burrel M, Iserte G, Forner A. Mauro E, et al. Cancers (Basel). 2023 Feb 15;15(4):1244. doi: 10.3390/cancers15041244. Cancers (Basel). 2023. PMID: 36831586 Free PMC article. Review.

8

Immunotherapy in biliary tract cancer: The race has begun!

Mauro E, Forner A. Mauro E, et al. Liver Int. 2023 Aug;43(8):1620-1622. doi: 10.1111/liv.15651. Liver Int. 2023. PMID: 37452502 No abstract available.

9

From evidence to clinical practice: Bridging the gap of new liver cancer therapies in Latin America.

Piñero F, Mauro E, Casciato P, Forner A. Piñero F, et al. Among authors: mauro e. Ann Hepatol. 2024 May-Jun;29(3):101185. doi: 10.1016/j.aohep.2023.101185. Epub 2023 Dec 1. Ann Hepatol. 2024. PMID: 38042481 Free article. Review.

10

Locoregional therapies for cholangiocarcinoma: Where they stand?

García-Criado Á, Soler A, Mauro E, Forner A. García-Criado Á, et al. Among authors: mauro e. Liver Int. 2024 Jun;44(6):1281-1282. doi: 10.1111/liv.15901. Liver Int. 2024. PMID: 38775383 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

328 results

Search Page